

Supernus and Indivior agree to merge in an all-stock deal, targeting $2.2 billion in revenue and $125 million in synergies.
You can purchase shares of Indivior Pharmaceuticals Inc Ordinary Share (NASDAQ:INDV) through any online brokerage.
There are no as such competitors for Indivior Pharmaceuticals Inc Ordinary Share.
Indivior Pharmaceuticals Inc Ordinary Share has a consensus price target of $37.60.
The stock price for Indivior Pharmaceuticals Inc Ordinary Share (NASDAQ: INDV) is $36.41 last updated November 2, 2026 at 6:25 PM EST.
There are no upcoming dividends for Indivior Pharmaceuticals Inc Ordinary Share.
Indivior Pharmaceuticals Inc Ordinary Share does not have any upcoming earnings scheduled.
There is no upcoming split for Indivior Pharmaceuticals Inc Ordinary Share.